» Articles » PMID: 28609432

Protective Effects of Amniotic Fluid in the Setting of Necrotizing Enterocolitis

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2017 Jun 14
PMID 28609432
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Necrotizing enterocolitis (NEC) is the most common life threatening condition affecting preterm infants. NEC occurs in 1-5% of all neonatal intensive care admissions and 5-10% of very low birth weight infants. The protective role of human breast milk (BM) has been well established. It has also been shown that amniotic fluid (AF) and BM have many similarities in terms of presence of growth and other immune-modulatory factors. This finding led to the initial hypothesis that AF may exert similar protective effects against the development of NEC, as does BM. Multiple studies have elucidated the presence of growth factors in AF and the protective effect of AF against NEC. Studies have also described possible mechanisms how AF protects against NEC. At present, research in this particular area is extremely active and robust. This review summarizes the various studies looking at the protective effects of AF against the development of NEC. It also provides an insight into future directions, the vast potential of AF as a readily available biologic medium, and the ethical barriers that must be overcome before using AF.

Citing Articles

Early life programming by diet can play a role in risk reduction of otitis in dogs.

Hemida M, Vuori K, Borgstrom N, Moore R, Rosendahl S, Anturaniemi J Front Vet Sci. 2023; 10:1186131.

PMID: 38026629 PMC: 10657834. DOI: 10.3389/fvets.2023.1186131.


Development of a new treatment for preterm birth complications using amniotic fluid stem cell therapy.

Abe Y, Sato Y, Tanaka M, Ochiai D Histol Histopathol. 2023; 38(9):965-974.

PMID: 36971371 DOI: 10.14670/HH-18-607.


Amniotic fluid stem cells: A novel treatment for necrotizing enterocolitis.

Balsamo F, Tian Y, Pierro A, Li B Front Pediatr. 2022; 10:1020986.

PMID: 36533245 PMC: 9751649. DOI: 10.3389/fped.2022.1020986.


Cell-Free Amniotic Fluid and Regenerative Medicine: Current Applications and Future Opportunities.

Bowen C, Ditmars F, Gupta A, Reems J, Fagg W Biomedicines. 2022; 10(11).

PMID: 36428527 PMC: 9687956. DOI: 10.3390/biomedicines10112960.


Stem cell therapy as a promising strategy in necrotizing enterocolitis.

Di S, Wu S, Liu T, Shi Y Mol Med. 2022; 28(1):107.

PMID: 36068527 PMC: 9450300. DOI: 10.1186/s10020-022-00536-y.


References
1.
Lemyre B, Xiu W, Rouvinez Bouali N, Brintnell J, Janigan J, Suh K . A decrease in the number of cases of necrotizing enterocolitis associated with the enhancement of infection prevention and control measures during a Staphylococcus aureus outbreak in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2011; 33(1):29-33. DOI: 10.1086/663343. View

2.
Christensen R, Havranek T, Gerstmann D, Calhoun D . Enteral administration of a simulated amniotic fluid to very low birth weight neonates. J Perinatol. 2005; 25(6):380-5. DOI: 10.1038/sj.jp.7211306. View

3.
Lucas A, Cole T . Breast milk and neonatal necrotising enterocolitis. Lancet. 1990; 336(8730):1519-23. DOI: 10.1016/0140-6736(90)93304-8. View

4.
Barmeyer C, Horak I, Zeitz M, Fromm M, Schulzke J . The interleukin-2-deficient mouse model. Pathobiology. 2003; 70(3):139-42. DOI: 10.1159/000068145. View

5.
Palsson-McDermott E, ONeill L . Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology. 2004; 113(2):153-62. PMC: 1782563. DOI: 10.1111/j.1365-2567.2004.01976.x. View